Pharmacokinetics of opioids in renal dysfunction

Clinical Pharmacokinetics
G DaviesM Street

Abstract

Patients with renal insufficiency commonly require the administration of an opioid analgesic to provide adequate pain relief. The handling of morphine, pethidine (meperidine) and dextropropoxyphene in patients with renal insufficiency is complicated by the potential accumulation of metabolites. While morphine itself remains largely unaffected by renal failure, accumulation, as denoted by an increase in both mean peak concentrations and the area under the concentration-time curve, of both the active metabolite (morphine-6-glucuronide) and the principal metabolite (morphine-3-glucuronide, thought to possess opiate antagonist properties) have been reported. The increased elimination half-lives of the toxic metabolites norpethidine and norpropoxyphene in patients with poor renal function administered pethidine and dextropropoxyphene, respectively, makes their routine use ill advised. Case reports of prolonged narcosis associated with the use of both codeine and dihydrocodeine in patients with renal insufficiency call for care to be used when prescribing these agents under such conditions. Although the pharmacokinetics of buprenorphine, alfentanil, sufentanil and remifentanil change little in patients with renal failure, the continu...Continue Reading

Citations

Sep 21, 2001·Indian Journal of Pediatrics·M Yaster, D G Nichols
Jun 23, 2009·European Journal of Clinical Pharmacology·Roger K Verbeeck, Flora T Musuamba
Feb 21, 2004·The Journal of Pain : Official Journal of the American Pain Society·Sebastiano Mercadante, Edoardo Arcuri
Jan 1, 1997·Peptides·G A OlsonA J Kastin
Aug 26, 1998·Journal of Cardiothoracic and Vascular Anesthesia·L M MontenegroP J Davis
Jan 19, 2002·European Journal of Pain : EJP·L E Mather
Jul 23, 2010·Journal of Psychoactive Drugs·Donald R Wesson, David E Smith
Jun 17, 2011·The Clinical Journal of Pain·Howard S Smith
Nov 17, 2007·International Journal of Clinical Practice·S M LeeH H Jung
Oct 24, 2007·Drugs & Aging·Blayne K Welk, Joel M H Teichman
Oct 31, 2002·Clinical Pharmacokinetics·Peter De PaepeWalter A Buylaert
Aug 12, 2008·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Arif MutwaliDonal Reddan
Mar 24, 2009·Paediatric Drugs·Boris ZernikowBrian J Anderson
Apr 1, 2008·Indian Journal of Nephrology·A De Sousa
Aug 6, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Manjula KurellaGlenn M Chertow
Dec 24, 2013·Journal of Palliative Medicine·David B Brecher, Tasheba L West
Dec 10, 2013·Postgraduate Medical Journal·Rachel Davison, Neil S Sheerin
Jul 23, 2013·Journal of Pain and Symptom Management·Che-Hao HsuShung-Tai Ho
Nov 17, 2012·The Surgical Clinics of North America·Larry Lindenbaum, David J Milia
Jun 9, 2009·Burns : Journal of the International Society for Burn Injuries·Kotaro Kaneda, Tae-Hyung Han
May 20, 2008·Clinics in Podiatric Medicine and Surgery·Stephen S Stern, Mario N Ponticello
May 29, 2007·Annales Françaises D'anesthèsie Et De Rèanimation·M JöhrS Ruesch
May 11, 2007·Best Practice & Research. Clinical Anaesthesiology·Narinder Rawal
Aug 24, 2005·Critical Care Nursing Clinics of North America·Dinesh YogaratnamBrian S Smith
Apr 17, 2013·Nephrology·Mark A BrownIlse Berquier
Feb 3, 2011·British Journal of Clinical Pharmacology·Andrew J McLachlanFiona M Blyth
Feb 13, 2014·Seminars in Dialysis·Sara N DavisonFrank Brennan
Jun 3, 2000·Pediatric Clinics of North America·M YasterL G Maxwell
Mar 10, 2005·The Medical Clinics of North America·Rory O'Hanlon, Donal N Reddan
Mar 10, 2005·The Medical Clinics of North America·Steven Gabardi, Stuart Abramson
Aug 13, 2015·Der Schmerz·M Schuler, N Grießinger
Apr 17, 2015·Seminars in Dialysis·Ameet KarambelkarPaul M Palevsky
Nov 23, 2013·Revista brasileira de anestesiologia·Isabel Flor de LimaCarlos Correia
May 20, 2003·Best Practice & Research. Clinical Anaesthesiology·Stephan A SchugGail Gillespie
Mar 20, 2015·Journal of Anaesthesiology, Clinical Pharmacology·Qutaiba A Tawfic, Geoff Bellingham
Dec 17, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Roger von MoosDaniele Santini
Jan 25, 2017·International Journal of Molecular Sciences·Mary MallappallilMoro Salifu
Feb 4, 1999·Critical Care Clinics·D F Volles, R McGory
Oct 31, 2002·Palliative Medicine·A RichR Ahmad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.